s6y

CytoDyn Inc.

Ticker
CYDY
CIK
1175680
Industry
Pharmaceutical Preparations
Formerly
CYTODYN INC, REXRAY CORP

Financials 104

  1. 10-Q Quarterly Report for period ending Aug 31, 2026
  2. 10-K Annual Report for period ending May 31, 2026
  3. 10-Q Quarterly Report for period ending Feb 28, 2026
  4. 10-Q Quarterly Report for period ending Nov 30, 2025
  5. 10-Q Quarterly Report for period ending Aug 31, 2025
  6. 10-K Annual Report for period ending May 31, 2025
  7. 10-Q Quarterly Report for period ending Feb 28, 2025
  8. 10-Q Quarterly Report for period ending Nov 30, 2024
  9. 10-Q Quarterly Report for period ending Aug 31, 2024
  10. 10-K/A Annual Report for period ending May 31, 2024

All 104 financials filings

News 329

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 329 news filings

Ownership 468

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 468 ownership filings

Prospectus 159

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-3 Registration statement for specified transactions by certain issuers
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 159 prospectus filings

Proxies 108

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 108 proxies filings

Other 234

  1. EFFECT Notice of Effectiveness
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. EFFECT Notice of Effectiveness
  7. D Exempt (Private) Offering
  8. EFFECT Notice of Effectiveness
  9. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  10. EFFECT Notice of Effectiveness

All 234 other filings